# Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

> **NCT05967052** · PHASE2 · RECRUITING · sponsor: **National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland** · enrollment: 132 (estimated)

## Conditions studied

- Chronic Fatigue Syndrome
- COVID-19, Long Haul

## Interventions

- **DRUG:** Pregabalin
- **BEHAVIORAL:** Independent walking training
- **DRUG:** Placebo
- **BEHAVIORAL:** Gradual movement therapy in the ward
- **BEHAVIORAL:** Telerehabilitation
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT05967052
- **Lead sponsor:** National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05967052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05967052, "Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05967052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*